Medical Device News Magazine

Testing the Lumena — World’s 1st Aerosol-safe NIV Mask

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

In the process of testing the world’s first aerosol-safe non-invasive ventilation (NIV) mask, a freelance scientist from open talent platform Kolabtree has supported Israeli medical device manufacturer Inspir Labs. The freelancer, Dr. Nicholas Miceli, carried out a statistical analysis comparing the infection risk for those wearing the new mask against competitive products. Inspir Labs used this analysis to better understand the implications of different silicone and polycarbonate types, mask-face dynamics, and more.

Aerosol-generating procedures (AGPs) create large amounts of small droplets that remain buoyant in the air, which carry a severe risk of infection for patients and healthcare workers. Unlike respiratory droplets, aerosols are small enough to penetrate or circumnavigate most surgical masks. At the start of the pandemic, this risk meant that many hospitals refrained from giving patients non-invasive ventilation (NIV) for fear of infection, leading to more intubations as a result. To combat this, Labs designed an NIV mask that uses a pressure gradient to prevent aerosol emissions from being released into the environment.

“We saw how the pandemic exacerbated the risk caused by aerosol hazards — developing NIV technology that takes into consideration not only the patient, but also the medical staff was the obvious solution,” explained Nadav Nahmias, Chief Technology Officer at Inspir Labs. “During product development, we needed to compare the infection risk for various common viruses in both non-vented and medium-vented hospital wards to see how effective our mask would be. We needed to quantify this information so that we could analyze and present it when applying for regulatory approvals and presenting it to physicians.”

Aerosol-safe NIV Mask

Inspir Labs posted the project on Kolabtree and was contacted by Dr. Nicholas Miceli, a freelance epidemiology expert. An associate professor of human resource management and healthcare management at Park University in Missouri, Nicholas was previously a researcher at the Ohio Department of Health and had also taught statistics and finite mathematics. This experience provided Nicholas with the necessary skills to carry out a statistical analysis for Inspir Labs, comparing the performance of the new aerosol-safe mask with competitive products.

“Inspir Labs provided me with a journal article that used a specific analytical method and requested that I replicate the analysis with the data provided,” explained Dr Miceli. “Working together with a colleague from Park University’s physics department, I found that the client’s mask performed better than the competition’s.”

Following this important statistical analysis, Inspir Labs progressed into sales processes and regulatory approvals. The mask has now received regulatory approval in Canada, Japan and Israel and is being used as an infection control device in multiple hospitals, keeping healthcare workers safe during AGPs.

Need a freelancer for your medical device project? Post your project for free https://www.kolabtree.com/create-project.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”